|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1007224849 |
| 003 |
OCoLC |
| 005 |
20231120010227.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
171020s2017 mauad ob 000 0 eng d |
| 040 |
|
|
|a IDEBK
|b eng
|e rda
|e pn
|c IDEBK
|d N$T
|d EBLCP
|d YDX
|d OPELS
|d OHS
|d OCLCO
|d MEU
|d UAB
|d OCLCO
|d UPM
|d D6H
|d OCLCF
|d OCLCO
|d OCLCQ
|d DKU
|d OCLCO
|d AU@
|d OCLCO
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d CASUM
|d OCL
|d OCLCO
|
| 019 |
|
|
|a 1007310184
|
| 020 |
|
|
|a 0128120177
|q (electronic bk.)
|
| 020 |
|
|
|a 9780128120170
|q (electronic bk.)
|
| 020 |
|
|
|a 9780128120163
|
| 020 |
|
|
|a 0128120169
|
| 035 |
|
|
|a (OCoLC)1007224849
|z (OCoLC)1007310184
|
| 050 |
|
4 |
|a RC270.8
|b .S454 2017eb
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.99406
|2 23
|
| 245 |
0 |
0 |
|a Selenium and Selenoproteins in Cancer /
|c edited by Kenneth D. Tew, Francesco Galli.
|
| 250 |
|
|
|a First edition.
|
| 264 |
|
1 |
|a Cambridge, MA :
|b Academic Press,
|c 2017.
|
| 300 |
|
|
|a 1 online resource (xiv, 302 pages) :
|b illustrations (some color), charts
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in cancer research ;
|v v. 136
|
| 546 |
|
|
|a Text in English.
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 505 |
0 |
|
|a Front Cover -- Selenium and Selenoproteins in Cancer -- Copyright -- Contents -- Contributors -- Preface -- Chapter One: The Epidemiology of Selenium and Human Cancer -- 1. Introduction -- 2. Selenium and Cancer: Scope of Research -- 3. Observational Studies -- 4. Randomized Controlled Trials -- 5. The Nutritional Prevention of Cancer Trial -- 6. The Selenium and Vitamin E Cancer Prevention Trial -- 7. The Other Trials -- 8. A Natural Experiment on Selenium and Cancer -- 9. Selenium in Cancer Therapy -- 10. Conclusion -- Acknowledgments -- References
|
| 505 |
8 |
|
|a Chapter Two: Selenoproteins in Tumorigenesis and Cancer Progression1. Introduction -- 2. Selenoprotein Production -- 3. Investigating Selenoproteins Through Sec tRNA Mutations -- 4. Role of Specific Selenoproteins in Tumorigenesis -- 4.1. Selenoprotein P -- 4.2. Glutathione Peroxidases -- 4.3. Thioredoxin Reductases -- 4.4. Selenoprotein F -- 5. Considerations and Conclusions -- Acknowledgments -- References -- Chapter Three: Selenoproteins and Metastasis -- 1. Introduction -- 2. Metastasis -- 2.1. Local Invasion -- 2.2. Intravasation
|
| 505 |
8 |
|
|a 2.3. Survival in Vasculature, Extravasation, and Formation of Micrometastases3. Dietary Selenium and Selenium Supplementation -- 4. Thioredoxin Reductases and Redox Tone -- 5. GPX and ROS Regulation -- 6. Selenoproteins Involved in ER Stress and Calcium Flux -- 7. Other Potential Roles for Selenoproteins in Metastasis -- 8. Conclusions -- Acknowledgments -- References -- Chapter Four: Selenium-Dependent Glutathione Peroxidases During Tumor Development -- 1. Introduction -- 2. Expression Profile of Se-Dependent GPxes in Different Types of Tumors
|
| 505 |
8 |
|
|a 3. Hydroperoxides and Redox Signaling During Cancer Development4. Impact of Individual GPxes on Tumor Development -- 4.1. GPx1 -- 4.1.1. Cell Death -- 4.1.2. Redox Signaling -- 4.1.3. Metabolism -- 4.2. GPx2 -- 4.2.1. Cell Death -- 4.2.2. Redox Signaling -- 4.3. GPx3 -- 4.3.1. Cell Death -- 4.3.2. Redox Signaling -- 4.4. GPx4 -- 4.4.1. Cell Death -- 4.4.2. Redox Signaling -- 5. Conclusions -- Acknowledgment -- References -- Chapter Five: Targeting the Selenoprotein Thioredoxin Reductase 1 for Anticancer Therapy -- 1. Introduction
|
| 505 |
8 |
|
|a 1.1. The Thioredoxin System1.2. Thioredoxin Reductase 1 -- 2. TrxR1 as an Important Enzyme in Cancer -- 3. Conclusions -- Acknowledgments -- References -- Chapter Six: The Regulation of Pathways of Inflammation and Resolution in Immune Cells and Cancer Stem Cells by Selenium -- 1. Tumor Microenvironment: Interplay With Immune Cells and Pathways of Inflammation -- 2. Selenium-Dependent Effects on Cancer Stem Cells in Leukemia -- 3. Interaction of LSCs With Immune Cells Mediated by CyPGs -- 4. Targeting LSC Metabolism With Selenium -- 5. Summary -- Acknowledgments
|
| 650 |
|
0 |
|a Cancer
|x Treatment.
|
| 650 |
|
0 |
|a Selenium
|x Physiological effect.
|
| 650 |
|
0 |
|a Selenoproteins
|x Physiological effect.
|
| 650 |
|
0 |
|a Selenium.
|
| 650 |
|
0 |
|a Selenoproteins.
|
| 650 |
|
2 |
|a Neoplasms
|x therapy
|0 (DNLM)D009369Q000628
|
| 650 |
|
2 |
|a Neoplasms
|0 (DNLM)D009369
|
| 650 |
|
2 |
|a Selenium
|0 (DNLM)D012643
|
| 650 |
|
2 |
|a Selenoproteins
|0 (DNLM)D051140
|
| 650 |
|
6 |
|a Cancer
|x Traitement.
|0 (CaQQLa)201-0004693
|
| 650 |
|
6 |
|a S�el�enium
|x Effets physiologiques.
|0 (CaQQLa)201-0028158
|
| 650 |
|
6 |
|a S�el�enoprot�eines
|0 (CaQQLa)000286271
|x Effets physiologiques.
|0 (CaQQLa)201-0374337
|
| 650 |
|
6 |
|a S�el�enium.
|0 (CaQQLa)201-0005075
|
| 650 |
|
6 |
|a S�el�enoprot�eines.
|0 (CaQQLa)000286271
|
| 650 |
|
7 |
|a selenium.
|2 aat
|0 (CStmoGRI)aat300156319
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Selenoproteins
|2 fast
|0 (OCoLC)fst01736533
|
| 650 |
|
7 |
|a Selenium
|2 fast
|0 (OCoLC)fst01111403
|
| 650 |
|
7 |
|a Cancer
|x Treatment
|2 fast
|0 (OCoLC)fst00845538
|
| 650 |
|
7 |
|a Selenium
|x Physiological effect
|2 fast
|0 (OCoLC)fst01111412
|
| 655 |
|
4 |
|a Internet Resources.
|
| 655 |
|
4 |
|a Charts.
|
| 655 |
|
4 |
|a Index not Present.
|
| 700 |
1 |
|
|a Tew, Kenneth D.,
|e editor.
|
| 700 |
1 |
|
|a Galli, Francesco,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Selenium and Selenoproteins in Cancer.
|b First edition.
|d Cambridge, MA : Academic Press, 2017
|z 9780128120163
|z 0128120169
|w (OCoLC)982089162
|
| 830 |
|
0 |
|a Advances in cancer research ;
|v v. 136.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/0065230X/136
|z Texto completo
|
